Be A Freedom Fighter · Bill Library
HR 10859 — Biotech Defense Act
Freedom score: -3 (scale −10 to +10)
- Individual rights: 0
- Property rights: 0
- Economic freedom: -1
- Privacy & due process: -1
- Government power: -1
Sponsor: Rep. Biggs, Sheri [R-SC-3] · Latest action: Referred to the Committee on Armed Services, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-10-22)
Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index
Findings — 5 highlighted provisions
Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.
- Sec. 2(d)(2)(A)–(D) · Economic Freedom — Establishes federal monitoring of foreign biotechnology investments, partnerships and joint ventures and coordination with CFIUS; no new transaction ban or fine is stated See in text ↓
- Sec. 2(d)(2)(D) · Privacy and Due Process — Requires an interagency database of foreign biotechnology-sector entities and government/military affiliations, potentially involving sensitive commercial information; no separate hearing/correction mechanism See in text ↓
- Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex See in text ↓
- Sec. 2(c)(1)–(3) · Government Power — Requires DNI to submit a China military-biotechnology assessment within 180 days, including supply-chain, military-civil fusion and potential countermeasures See in text ↓
- Sec. 2(d)(1)–(3) · Government Power — Requires DoD to convene a biotechnology risk contact group within 180 days, coordinate with CFIUS, maintain a foreign-entity database, report annually and brief Congress every 90 days after initial briefing. No appropriation or new criminal sanction See in text ↓
Full text (introduced version)
17 of 30 text blocks highlighted. Source: GovInfo, fetched cached.
SECTION 1. SHORT TITLE.
SEC. 2. COUNTERING BIOTECHNOLOGY THREATS FROM THE PEOPLE'S REPUBLIC OF CHINA.
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(b), new 10 U.S.C. §118d(a)–(d) · Government Power — Requires DoD to integrate foreign biotechnology threats into national defense strategy and guidance, consult agencies and industry, and report to Congress with optional classified annex
Sec. 2(c)(1)–(3) · Government Power — Requires DNI to submit a China military-biotechnology assessment within 180 days, including supply-chain, military-civil fusion and potential countermeasures
Sec. 2(c)(1)–(3) · Government Power — Requires DNI to submit a China military-biotechnology assessment within 180 days, including supply-chain, military-civil fusion and potential countermeasures
Sec. 2(c)(1)–(3) · Government Power — Requires DNI to submit a China military-biotechnology assessment within 180 days, including supply-chain, military-civil fusion and potential countermeasures
Sec. 2(c)(1)–(3) · Government Power — Requires DNI to submit a China military-biotechnology assessment within 180 days, including supply-chain, military-civil fusion and potential countermeasures
Sec. 2(d)(2)(A)–(D) · Economic Freedom — Establishes federal monitoring of foreign biotechnology investments, partnerships and joint ventures and coordination with CFIUS; no new transaction ban or fine is stated
Sec. 2(d)(2)(D) · Privacy and Due Process — Requires an interagency database of foreign biotechnology-sector entities and government/military affiliations, potentially involving sensitive commercial information; no separate hearing/correction mechanism
Sec. 2(d)(1)–(3) · Government Power — Requires DoD to convene a biotechnology risk contact group within 180 days, coordinate with CFIUS, maintain a foreign-entity database, report annually and brief Congress every 90 days after initial briefing. No appropriation or new criminal sanction
Sec. 2(d)(1)–(3) · Government Power — Requires DoD to convene a biotechnology risk contact group within 180 days, coordinate with CFIUS, maintain a foreign-entity database, report annually and brief Congress every 90 days after initial briefing. No appropriation or new criminal sanction
Sec. 2(d)(2)(A)–(D) · Economic Freedom — Establishes federal monitoring of foreign biotechnology investments, partnerships and joint ventures and coordination with CFIUS; no new transaction ban or fine is stated
Sec. 2(d)(2)(D) · Privacy and Due Process — Requires an interagency database of foreign biotechnology-sector entities and government/military affiliations, potentially involving sensitive commercial information; no separate hearing/correction mechanism
Sec. 2(d)(1)–(3) · Government Power — Requires DoD to convene a biotechnology risk contact group within 180 days, coordinate with CFIUS, maintain a foreign-entity database, report annually and brief Congress every 90 days after initial briefing. No appropriation or new criminal sanction
Sec. 2(d)(1)–(3) · Government Power — Requires DoD to convene a biotechnology risk contact group within 180 days, coordinate with CFIUS, maintain a foreign-entity database, report annually and brief Congress every 90 days after initial briefing. No appropriation or new criminal sanction
Findings source: bill-scores-v2-batch33-findings-2026-11-14.md. Highlights come only from that file; no finding, score, or provision was invented for this page.
What you can do
Contact your U.S. Representative and Senators about this bill.
Find your Representative Contact your Senators
Spot an error on this page? Report it.